618 related articles for article (PubMed ID: 30778201)
1. The transcription factor c-Jun/AP-1 promotes liver fibrosis during non-alcoholic steatohepatitis by regulating Osteopontin expression.
Schulien I; Hockenjos B; Schmitt-Graeff A; Perdekamp MG; Follo M; Thimme R; Hasselblatt P
Cell Death Differ; 2019 Sep; 26(9):1688-1699. PubMed ID: 30778201
[TBL] [Abstract][Full Text] [Related]
2. Osteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosis.
Coombes JD; Choi SS; Swiderska-Syn M; Manka P; Reid DT; Palma E; Briones-Orta MA; Xie G; Younis R; Kitamura N; Della Peruta M; Bitencourt S; Dollé L; Oo YH; Mi Z; Kuo PC; Williams R; Chokshi S; Canbay A; Claridge LC; Eksteen B; Diehl AM; Syn WK
Biochim Biophys Acta; 2016 Jan; 1862(1):135-44. PubMed ID: 26529285
[TBL] [Abstract][Full Text] [Related]
3. CD44 is a key player in non-alcoholic steatohepatitis.
Patouraux S; Rousseau D; Bonnafous S; Lebeaupin C; Luci C; Canivet CM; Schneck AS; Bertola A; Saint-Paul MC; Iannelli A; Gugenheim J; Anty R; Tran A; Bailly-Maitre B; Gual P
J Hepatol; 2017 Aug; 67(2):328-338. PubMed ID: 28323124
[TBL] [Abstract][Full Text] [Related]
4. Targeting NFATc4 attenuates non-alcoholic steatohepatitis in mice.
Du M; Wang X; Yuan L; Liu B; Mao X; Huang D; Yang L; Huang K; Zhang F; Wang Y; Luo X; Wang C; Peng J; Liang M; Huang D; Huang K
J Hepatol; 2020 Dec; 73(6):1333-1346. PubMed ID: 32717288
[TBL] [Abstract][Full Text] [Related]
5. Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice.
Kim KH; Kim SH; Han DH; Jo YS; Lee YH; Lee MS
Sci Rep; 2018 May; 8(1):6789. PubMed ID: 29717162
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis.
Syn WK; Choi SS; Liaskou E; Karaca GF; Agboola KM; Oo YH; Mi Z; Pereira TA; Zdanowicz M; Malladi P; Chen Y; Moylan C; Jung Y; Bhattacharya SD; Teaberry V; Omenetti A; Abdelmalek MF; Guy CD; Adams DH; Kuo PC; Michelotti GA; Whitington PF; Diehl AM
Hepatology; 2011 Jan; 53(1):106-15. PubMed ID: 20967826
[TBL] [Abstract][Full Text] [Related]
7. The Annexin A2-Notch regulatory loop in hepatocytes promotes liver fibrosis in NAFLD by increasing osteopontin expression.
Wang G; Duan J; Pu G; Ye C; Li Y; Xiu W; Xu J; Liu B; Zhu Y; Wang C
Biochim Biophys Acta Mol Basis Dis; 2022 Aug; 1868(8):166413. PubMed ID: 35413401
[TBL] [Abstract][Full Text] [Related]
8. Lipid-injured hepatocytes release sOPN to improve macrophage migration via CD44 engagement and pFak-NFκB signaling.
Jiang X; Zhang F; Ji X; Dong F; Yu H; Xue M; Qiu Y; Yang F; Hu X; Bao Z
Cytokine; 2021 Jun; 142():155474. PubMed ID: 33647584
[TBL] [Abstract][Full Text] [Related]
9. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
[TBL] [Abstract][Full Text] [Related]
10. NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease.
Syn WK; Agboola KM; Swiderska M; Michelotti GA; Liaskou E; Pang H; Xie G; Philips G; Chan IS; Karaca GF; Pereira Tde A; Chen Y; Mi Z; Kuo PC; Choi SS; Guy CD; Abdelmalek MF; Diehl AM
Gut; 2012 Sep; 61(9):1323-9. PubMed ID: 22427237
[TBL] [Abstract][Full Text] [Related]
11. Intrahepatic osteopontin signaling by CREBZF defines a checkpoint for steatosis-to-NASH progression.
Ma F; Liu Y; Hu Z; Xue Y; Liu Z; Cai G; Su W; Zheng Z; Fang X; Yan X; Ding D; Sun X; Jiang Y; Wei S; Li W; Zhao J; Zhang H; Li H; Xiao D; Zhang C; Ying H; Qin J; Gao X; Dai X; Fu W; Xu Y; Li Y; Cui A
Hepatology; 2023 Nov; 78(5):1492-1505. PubMed ID: 36680394
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis.
Zhu C; Kim K; Wang X; Bartolome A; Salomao M; Dongiovanni P; Meroni M; Graham MJ; Yates KP; Diehl AM; Schwabe RF; Tabas I; Valenti L; Lavine JE; Pajvani UB
Sci Transl Med; 2018 Nov; 10(468):. PubMed ID: 30463916
[TBL] [Abstract][Full Text] [Related]
13. Macrophage-derived Osteopontin (SPP1) Protects From Nonalcoholic Steatohepatitis.
Han H; Ge X; Komakula SSB; Desert R; Das S; Song Z; Chen W; Athavale D; Gaskell H; Lantvit D; Guzman G; Nieto N
Gastroenterology; 2023 Jul; 165(1):201-217. PubMed ID: 37028770
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model.
Sahai A; Malladi P; Melin-Aldana H; Green RM; Whitington PF
Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G264-73. PubMed ID: 15044174
[TBL] [Abstract][Full Text] [Related]
15. Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice.
Lytle KA; Wong CP; Jump DB
PLoS One; 2017; 12(4):e0173376. PubMed ID: 28422962
[TBL] [Abstract][Full Text] [Related]
16. Role of XBP1 in regulating the progression of non-alcoholic steatohepatitis.
Wang Q; Zhou H; Bu Q; Wei S; Li L; Zhou J; Zhou S; Su W; Liu M; Liu Z; Wang M; Lu L
J Hepatol; 2022 Aug; 77(2):312-325. PubMed ID: 35292349
[TBL] [Abstract][Full Text] [Related]
17. The transcription factor c-JUN/AP-1 promotes HBV-related liver tumorigenesis in mice.
Trierweiler C; Hockenjos B; Zatloukal K; Thimme R; Blum HE; Wagner EF; Hasselblatt P
Cell Death Differ; 2016 Apr; 23(4):576-82. PubMed ID: 26470729
[TBL] [Abstract][Full Text] [Related]
18. Hepatocyte specific deletion of c-Met leads to the development of severe non-alcoholic steatohepatitis in mice.
Kroy DC; Schumacher F; Ramadori P; Hatting M; Bergheim I; Gassler N; Boekschoten MV; Müller M; Streetz KL; Trautwein C
J Hepatol; 2014 Oct; 61(4):883-90. PubMed ID: 24845607
[TBL] [Abstract][Full Text] [Related]
19. Liver-specific loss of Perilipin 2 alleviates diet-induced hepatic steatosis, inflammation, and fibrosis.
Najt CP; Senthivinayagam S; Aljazi MB; Fader KA; Olenic SD; Brock JR; Lydic TA; Jones AD; Atshaves BP
Am J Physiol Gastrointest Liver Physiol; 2016 May; 310(9):G726-38. PubMed ID: 26968211
[TBL] [Abstract][Full Text] [Related]
20. c-Met Signaling Protects from Nonalcoholic Steatohepatitis- (NASH-) Induced Fibrosis in Different Liver Cell Types.
Drescher HK; Schumacher F; Schenker T; Baues M; Lammers T; Hieronymus T; Trautwein C; Streetz KL; Kroy DC
Oxid Med Cell Longev; 2018; 2018():6957497. PubMed ID: 30538805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
